|
|
|||||||||
Basic Science Investigations |
1 PET Center, Division of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland
2 Center for Radiopharmaceutical Science of ETH, PSI, and USZ, Paul Scherrer Institute, Villigen, und University Hospital Zurich, Zurich, Switzerland
3 Section of Diagnostic Imaging and Radio-Oncology, Veterinary Hospital, University Zurich, Zurich, Switzerland
4 Institute of Diagnostic Radiology, University Hospital Zurich, Zurich, Switzerland
5 Division of Radiation Medicine, Paul Scherrer Institute, Villigen, Switzerland
6 Institute of Neuropathology, Department of Pathology, University Hospital Zurich, Zurich, Switzerland
7 Department of Neurology, University Hospital Zurich, Zurich, Switzerland
Differentiation between posttherapy radiation necrosis and recurrent tumor in humans with brain tumor is still a difficult diagnostic task. The new PET tracers 18F-fluoro-ethyl-L-tyrosine (FET) and 18F-fluorocholine (N,N-dimethyl-N-18F-fluoromethyl-2-hydroxyethylammonium [FCH]) have shown promise for improving diagnostic accuracy. This study assessed uptake of these tracers in experimental radiation injury. Methods: In a first model, circumscribed lesions were induced in the cortex of 35 rats using proton irradiation of 150 or 250 Gy. After radiation injury developed, uptake of 18F-FET, 18F-FCH, and 18F-FDG was measured using autoradiography and correlated with histology and disruption of the blood-brain barrier as determined with Evans blue. In a second model, uptake of the tracers was assessed in acute cryolesions, which are characterized by the absence of inflammatory cells. Results: Mean 18F-FET, 18F-FCH, and 18F-FDG standardized uptake values in the most active part of the radiation lesion and the contralateral normal cortex (in parentheses) were 2.27 ± 0.46 (1.42 ± 0.23), 2.52 ± 0.42 (0.61 ± 0.12), and 6.21 ± 1.19 (4.35 ± 0.47). The degree of uptake of 18F-FCH and 18F-FDG correlated with the density of macrophages. In cryolesions, 18F-FET uptake was similar to that in radiation lesions, and 18F-FCH uptake was significantly reduced. Conclusion: Comparison of tracer accumulation in cryolesions and radiation injuries demonstrates that 18F-FET uptake is most likely due to a disruption of the blood-brain barrier alone, whereas 18F-FCH is additionally trapped by macrophages. Uptake of both tracers in the radiation injuries is generally lower than the published uptake in tumors, suggesting that 18F-FET and 18F-FCH are promising tracers for separating radiation necrosis from tumor recurrence. However, the comparability of our data with the literature is limited by factors such as different species and acquisition protocols and modalities. Thus, more studies are needed to settle this issue. Nevertheless, 18F-FCH and 18F-FET seem superior to 18F-FDG for this purpose.
Key Words: radiation necrosis 18F-fluorocholine 18F-fluoroethyl-L-tyrosine 18F-FDG autoradiography
Related articles in JNM:
This article has been cited by other articles:
![]() |
C. Plathow and W. A. Weber Tumor Cell Metabolism Imaging J. Nucl. Med., June 1, 2008; 49(Suppl_2): 43S - 63S. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Stadlbauer, O. Prante, C. Nimsky, E. Salomonowitz, M. Buchfelder, T. Kuwert, R. Linke, and O. Ganslandt Metabolic Imaging of Cerebral Gliomas: Spatial Correlation of Changes in O-(2-18F-Fluoroethyl)-L-Tyrosine PET and Proton Magnetic Resonance Spectroscopic Imaging J. Nucl. Med., May 1, 2008; 49(5): 721 - 729. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Salber, G. Stoffels, D. Pauleit, A.-M. Oros-Peusquens, N. J. Shah, P. Klauth, K. Hamacher, H. H. Coenen, and K.-J. Langen Differential Uptake of O-(2-18F-Fluoroethyl)-L-Tyrosine, L-3H-Methionine, and 3H-Deoxyglucose in Brain Abscesses J. Nucl. Med., December 1, 2007; 48(12): 2056 - 2062. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Chen Clinical Applications of PET in Brain Tumors J. Nucl. Med., September 1, 2007; 48(9): 1468 - 1481. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Kwee, J. P. Ko, C. S. Jiang, M. R. Watters, and M. N. Coel Solitary Brain Lesions Enhancing at MR Imaging: Evaluation with Fluorine 18 Fluorocholine PET Radiology, August 1, 2007; 244(2): 557 - 565. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Rutten, J.-E. Cabay, N. Withofs, C. Lemaire, J. Aerts, V. Baart, and R. Hustinx PET/CT of Skull Base Meningiomas Using 2-18F-Fluoro-L-Tyrosine: Initial Report J. Nucl. Med., May 1, 2007; 48(5): 720 - 725. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Wyss, N. Spaeth, G. Biollaz, J. Pahnke, P. Alessi, E. Trachsel, V. Treyer, B. Weber, D. Neri, and A. Buck Uptake of 18F-Fluorocholine, 18F-FET, and 18F-FDG in C6 Gliomas and Correlation with 131I-SIP(L19), a Marker of Angiogenesis J. Nucl. Med., April 1, 2007; 48(4): 608 - 614. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-C. Chan, T.-C. Yen, S.-H. Ng, C.-Y. Lin, H.-M. Wang, C.-T. Liao, K.-H. Fan, and J. T.-C. Chang Differential Roles of 18F-FDG PET in Patients with Locoregional Advanced Nasopharyngeal Carcinoma After Primary Curative Therapy: Response Evaluation and Impact on Management J. Nucl. Med., September 1, 2006; 47(9): 1447 - 1454. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Matter, M. T. Wyss, P. Meier, N. Spath, T. von Lukowicz, C. Lohmann, B. Weber, A. R. de Molina, J. C. Lacal, S. M. Ametamey, et al. 18F-Choline Images Murine Atherosclerotic Plaques Ex Vivo Arterioscler Thromb Vasc Biol, March 1, 2006; 26(3): 584 - 589. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | RSS | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |